Hypogonadism

Severe COVID-19 Associated With Low Testosterone in Men

Publish Date May 27, 2021

It is unclear whether low testosterone is a marker or a mediator of severe and impending severe COVID-19 illness.

Inflammatory Diet May Contribute to Testosterone Deficiency in Men

Publish Date April 29, 2021

Each 1 unit increment in Dietary Inflammatory Index was associated with a 4.0% increase in the odds of testosterone deficiency.

Kyzatrex Under Review for Primary and Secondary Male Hypogonadism

Publish Date March 16, 2021

Kyzatrex is an investigational, oral testosterone undecanoate softgel that utilizes lymphatic absorption and phytosterols to increase bioavailability and provide a favorable pharmacokinetic profile.

Kidney Stones Linked With Osteoporosis, Fractures

Publish Date March 10, 2021

Bone loss in patients with kidney stone disease, particularly in men, has been underappreciated in clinical practice, according to investigators.

Testosterone Therapy May Reduce Diabetes Risk

Publish Date January 8, 2021

Additional safety data on testosterone therapy are needed before it can be used to prevent type 2 diabetes.

Nasal Gel Ups Testosterone, Maintains Semen Parameters

Publish Date May 6, 2020

In a study, most symptomatic hypogonadal men treated with Natesto, a short-acting 4.5% nasal testosterone gel, attained normal testosterone levels at 6 months while preserving sperm counts.

Jatenzo, an Oral Testosterone Replacement Therapy, Now Available

Publish Date February 18, 2020

Jatenzo® (testosterone undecanoate; Clarus Therapeutics), an oral testosterone replacement therapy, is now available for the treatment of hypogonadism.

New Testosterone Therapy Guideline Issued for Age-Related Low T

Publish Date January 7, 2020

According to the American College of Physicians’ guideline, clinicians should prescribe testosterone treatment only to men with sexual dysfunction symptoms.

Testosterone Replacement May Benefit Younger Male Cancer Survivors

Publish Date December 24, 2019

Benefits include significant improvement in body composition measurements over 6 months.

Waist Circumference Affects Coronary Plaque Accumulation in Testosterone Therapy

Publish Date December 20, 2019

Older men receiving testosterone treatment with higher waist-to-hip ratio experience greater increases in noncalcified coronary plaque volume.